Kevin Gorman | CEO & Director |
Jane Sorensen | IR |
Matthew Abernethy | CFO |
Eric Benevich | Chief Commercial Officer |
Eiry Roberts | Chief Medical Officer |
Geoffrey Meacham | Barclays |
Brian Skorney | Baird |
Tazeen Ahmad | Bank of America |
Anupam Rama | JPMorgan |
Jay Olson | Oppenheimer |
Philip Nadeau | Cowen and Company |
Biren Amin | Jefferies |
Alan Carr | Needham & Company |
Sumant Kulkarni | Cannacord |
David Amsellem | Piper Jaffray |
Good day, everyone, and welcome to Neurocrine Biosciences Reports Second Quarter 2018 Results. [Operator Instructions] It is now my pleasure to turn the conference over to, Kevin Gorman, CEO. Please go ahead sir.
Thank you very much, and welcome, everyone to our quarterly conference call.
Before we start, we’re going to be making forward-looking statements.